WELL Health Technologies controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2021
Criticism of the acquisition-driven roll-up model
An analysis published in April 2021 described WELL as a potentially toxic roll-up and accused it of malpractice involving aspects of its business and the CRH acquisition. Other analysts disagreed. The reference material does not establish the allegations as adjudicated misconduct.